Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2023 > Vol 4, №8 (2023) > Macroglobulinemia: hidden by anemia (clinical case report)

Macroglobulinemia: hidden by anemia (clinical case report)

Svetlana M. Khokhlova , Olga N. Pasyuta , Julia B. Chervyakova , Margarita A. Gromova , Julia G. Patraman , Marianna R. Mazra , Alexander A. Kopelev , Tamara O. Myshlyaeva

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Waldenström macroglobulinemia (WM) is a type of plasma cell disease that is a malignant B-cell lymphoplasmacytic lymphoma. In patients with WM, immunological blood tests may remain unchanged for a while without pathological changes, but then tumor infiltration of the bone marrow gradually leads to anemia and thrombocytopenia. This patient has anemic syndrome according to clinical and laboratory examination, in which a number of diseases were diagnosed. An early diagnostic method, electrophoresis allows the consideration of immunoproliferative disorders with monoclonal IgM. Immunotyping is widely used with the eye chart of gammopathies using antisera to light (G, A, M) and light (kappa, lambda) chains of immunoglobulins. An increase in blood vessels IgM > 30 g/l, when identified with neurological symptoms of the source, associate these manifestations with hyperviscosity syndrome in WM.
Key words: macroglobulinemia, plasma cell diseases, hyperviscosity syndrome, monoclonal IgM, immunoproliferative disorders.

About the Author

Svetlana M. Khokhlova 1 , Olga N. Pasyuta 1 , Julia B. Chervyakova 1 , Margarita A. Gromova 1 , Julia G. Patraman 2 , Marianna R. Mazra 1 , Alexander A. Kopelev 1 , Tamara O. Myshlyaeva 1

1 Pirogov Russian National Research Medical University, Moscow, Russia

2 Bauman City Clinical Hospital No29, Moscow, Russia

References

1. Gertz MA. Waldenstrom macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023; 98 (2): 348–58. DOI: 10.1002/ajh.26796
2. Sanchez E, Tanenbaum EJ, Patil S et al. The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker. Expert Rev Mol Diagn. 2018; 18 (4): 319–29. DOI: 10.1080/14737159.2018.1448269
3. Макроглобулинемия Вальденстрема. Клинические рекомендации. Национальное гематологическое общество совместно с Ассоциацией онкологов России. М., 2023. Ссылка активна на 05.11.2023. URL: https: //npngo.ru/uploads/media_document/733/54fd2ceb-240c-4577-af6d-7752f0e10c06.docx
Waldenström macroglobulinemia. Clinical guidelines. The National Hematology Society together with the Association of Oncologists of Russia. URL: https: //npngo.ru/uploads/media_document/733/ 54fd2ceb-240c-4577-af6d-7752f0e10c06.docx (in Russian).
4. Kaseb H, Gonzalez-Mosquera LF, Parsi M, Mewawalla P. Lymphoplasmacytic lymphoma. Treasure Island (FL): StatPearls Publishing; 2023.
5. Балакирева Т.В., Андреева Н.Е. Макроглобулинемия Вальденстрема. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2009; 2 (2): 121–36. Ссылка активна на 05.11.2023. URL: https: //cyberleninka.ru/article/n/makroglobulinemiya-valdenstrema/viewer
Balakireva TV, Andreeva NE. Waldenström's macroglobulinemia. Clinical oncohematology. Basic Research and Clinical Practice. 2009; 2 (2): 121–36. URL: https: //cyberleninka.ru/article/n/makroglobulinemiya-valdenstrema/viewer (in Russian).
6. Hunter ZR, Xu L, Yang G et al. The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2014; 123 (11): 1637–46. DOI: 10.1182/blood-2013-09-525808
7. Monge J, Braggio E, Ansell SM. Genetic factors and pathogenesis of Waldenström's macroglobulinemia. Curr Oncol Rep. 2013; 15 (5): 450–6. DOI: 10.1007/s11912-013-0331-7
8. Фиясь А.Т., Чайковская О.П., Пищик Е.О., Френкель Б.И. К вопросу о макроглобулинемии Вальденстрема. Журнал ГрГМУ. 2010; (3): 95–7. Ссылка активна на 05.11.2023. URL: http: //journal-grsmu.by/index.php/ojs/article/view/607/538
Fiyas AT, Chaikovskaya OP, Pishchik EO, Frenkel BI. On the issue of Waldenström's macroglobulinemia. Journal GrSMU. 2010; (3): 95–7. URL: http: //journal-grsmu.by/index.php/ojs/article/view/607/538 (in Russian).
9. Vos JM, Gustine J, Rennke HG et al. Renal disease related to Waldenstrom macroglobulinacmia: incidence. pathology and clinical outcomes. Br J Haematol. 2016; 175 (4): 623–30. DOI: 10.1111/bjh.
14279
10. Askari E, Rodriguez S, Garcia-Sanz R. Waldenström’s Macroglobulinemia: An Exploration into the Pathology and Diagnosis of a Complex B-Cell Malignancy. J Blood Med. 2021; 12: 795–807. DOI: 10.2147/JBM.S267938
11. Nobile-Orazio E. Antigenic determinants in IgM paraprotein-related neuropathies. Clin. Lymph. Myeloma 2009; 9 (1): 107–9. DOI: 10.3816/CLM.2009.n.02
12. Дзеранова Н.Я., Кудряшова Е.Ю., Никитина А.В., Исаков В.А. Макроглобулинемия Вальденстрема: диагностика в клинической практике. Медицина: теория и практика. 2018; 3 (3): 10–5. Ссылка активна на 05.11.2023. URL: https: //ojs3.gpmu.org/index.php/med-theory-and-practice/article/view/495
Dzeranova NYa, Kudryashova EYu, Nikitina AV, Isakov VA. Waldenström macroglobulinemia: diagnostics in clinical practice. Medicine: theor and practice. 2018; 3 (3): 10–5. URL: https: //ojs3.gpmu.org/ index.php/med-theory-and-practice/article/view/495 (in Russian).
13. Khwaja J, D’Sa S, Minnema MC et al. IgM monoclonal gammopathies of clinical significance: diagnosis and management. Haematologica. 2022; 107 (9): 2037–50; DOI: 10.3324/haematol.2022.280953
14. Castillo JJ, Ghobrial IM, Treon SP. Biology, prognosis, and therapy of Waldenström Macroglobulinemia. Cancer Treat Res. 2015; 165: 177–95. DOI: 10.1007/978-3-319-13150-4_7
15. Kolikkat N, Moideen S, Khader A et al. Waldenstrom's Macroglobulinemia: A case report. J Family Med Prim Care. 2020; 9 (3): 1768–71. DOI: 10.4103/jfmpc.jfmpc_972_19

For citation:Khokhlova S.M., Pasyuta O.N., Chervyakova Ju.B. et al. Macroglobulinemia: hidden by anemia (clinical case report). Clinical review for general practice. 2023; 4 (8): 101–105 (In Russ.). DOI: 10.47407/kr2023.4.8.00337


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru